-

Bayer Signs Letter of Intent to Build New Distribution Center in Saxonburg, PA

New 220,000 square-foot Distribution Center to support ongoing growth of business

PITTSBURGH--(BUSINESS WIRE)--Bayer announced its plans to build a new 220,000 sq. ft. Distribution Center to support the ongoing growth of Bayer’s Radiology global business that supplies medical device products world-wide. A 10-year lease with optional extensions is being negotiated.

The facility, which will be operated and staffed by FedEx Supply Chain, is in response to growing product demand and steady growth of the business over the past few years. It allows for flexibility for future growth, including an additional expansion option of up to 80,000 sq. ft.

The Distribution Center will warehouse and distribute Bayer’s contrast injectors and sterile disposables kits used for the power injection of contrast-enhanced imaging procedures manufactured at Bayer’s local manufacturing operations in O’Hara, Saxonburg and Indianola. Its lease at the current distribution center, located in New Galilee, Pennsylvania is set to expire in March of 2022.

Included in the building design will be 28 Loading Docks, 1 drive in dock and 1 compactor, 60 tractor-trailer staging and administrative office spaces. It will be located within a mile of the Saxonburg manufacturing site.

Bayer’s Radiology products support imaging procedures in over 95% of the top 50 hospitals in the U.S. The products we make locally support Radiologists and health care providers to make diagnoses, and guide treatment decisions across health conditions and chronic diseases. Our portfolio includes medical devices, contrast media, Radiology software and equipment service across a broad range of imaging modalities, including CT, MR, PET, Interventional and Angiography.

“We are excited to build upon over 50 years of history serving our global customers from the Pittsburgh region, with the construction of this new Distribution Center,” stated Jeff Owoc, Bayer’s Senior Vice President and Global Head of Medical Device Operations. “The center will not only allow for future growth of our Radiology business but will enable us to continue to invest in the local Pittsburgh community.”

Additionally, the new center will feature updated warehouse and labor management systems as well as enhanced system connectivity aimed at improving transactional speed and accuracy. Coupled with automated conveyance systems, the new center will drive higher efficiencies and accuracy into the supply chain management process.

"FedEx Supply Chain is honored to be the supplier of choice for Bayer’s new distribution facility in Pittsburgh,” said Andy Smith, FedEx Supply Chain SVP and COO. "We look forward to managing and streamlining Bayer's supply chain needs so they can maintain focus on their customers and growing their business.”

Bayer has approximately 1,300 employees in Pittsburgh that support the Radiology business and other global operations.

Contacts

Jennifer May
Bayer U.S.
Jennifer.may@bayer.com
Mobile: (412) 656-8192

Bayer


Release Versions

Contacts

Jennifer May
Bayer U.S.
Jennifer.may@bayer.com
Mobile: (412) 656-8192

More News From Bayer

Federal Judge Remands Monsanto Class Settlement Case Back to MO State Court

LEVERKUSEN, Germany & ST. LOUIS--(BUSINESS WIRE)--Today, Judge Henry E. Autrey, a federal district court judge in the Eastern District of Missouri, today issued a ruling remanding the class settlement case, King v Monsanto, back to Missouri State Court. Monsanto released the following statement in response to the Court’s decision. “This decision returns jurisdiction over the class settlement to Missouri Circuit Court where the vast majority of pending claims in the Roundup litigation have been...

Bayer Completes Acquisition of Perfuse Therapeutics

BERLIN--(BUSINESS WIRE)--Bayer today announced the completion of the acquisition of Perfuse Therapeutics, Inc. As a result, Perfuse Therapeutics will now be fully integrated into Bayer. As announced previously, Bayer now holds the full rights pertaining to PER-001 intravitreal implant, a first in class, sustained release small molecule endothelin receptor antagonist currently in Phase II clinical development for the treatment of Glaucoma and Diabetic Retinopathy (DR). This acquisition strengthe...

Aleve® Launches its Project DIY Campaign with HGTV Stars Dave & Jenny Marrs to Highlight Hardworking Hobbyists and Long-Lasting Pain Relief

WHIPPANY, N.J.--(BUSINESS WIRE)--Today, Aleve® announced the launch of its Project DIY Campaign, a new DIY-focused marketing initiative under the recently launched Feel Aleve® platform, featuring HGTV stars, Dave and Jenny Marrs. The activation centers around a home transformation project where Dave and Jenny Marrs renovated a family's back porch, taking a non-functioning space and making it into a space the whole family can use and enjoy and bringing to life what it means to Feel Aleve – up to...
Back to Newsroom